Tvardi Therapeutics, Inc. (TVRD) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-11

Tvardi Therapeutics, Inc. (TVRD) has filed 5 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-11. 3 Form 8-K material event filings were reported by TVRD in the last 90 days. InsiderAlpha tracks every TVRD SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Tvardi Therapeutics, Inc. (TVRD)

SEC CIK	0001346830

90-Day SEC Filing Activity

Form 4 filings (90d)	5
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-06-11

Recent TVRD Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-07-07	Tweardy Samuel David	Insider	J — Other acquisition / disposition	315.7K	$0.00	—	SEC
2025-07-07	Tweardy Samuel David	Insider	J — Other acquisition / disposition	315.7K	$0.00	—	SEC
2024-11-04	Posner Christopher	PRESIDENT AND CEO	S — Open-market sale [10b5-1]	3.7K	$0.29	$1K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Tvardi Therapeutics, Inc. (TVRD). Updated in real time as new filings are submitted to the SEC.

Most-Active TVRD Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Smith Cynthia	1	—
WYZGA MICHAEL S	1	—
Shiff Susan Ph.D.	1	—
Shah Sujal	1	—
HALL WALLACE L JR	1	—

Recent TVRD Form 8-K Material Events

2026-07-07 — Item 7.01, 9.01 [SEC]
2026-06-11 — Item 5.07 [SEC]
2026-05-08 — Item 2.02, 9.01 [SEC]
2026-03-31 — Item 2.02, 9.01 · Earnings · neutral [SEC]
Tvardi Therapeutics announced financial results and business highlights for the fiscal quarter and year ended December 31, 2025 via press release on March 31, 2026. The filing provides standard results reporting without explicit beat/miss or guidance language.
2026-03-06 — Item 8.01 · Other · neutral [SEC]
Tvardi Therapeutics announced that its 2026 Annual Meeting of Stockholders will be held on June 9, 2026. The company established March 16, 2026 as the deadline for stockholder proposals and board nominations to be included in proxy materials, in accordance with SEC Rule 14a-8 and

Recent Insider Filings

2026-06-11 — Shiff Susan Ph.D. (Insider)
2026-06-11 — Smith Cynthia (Insider)
2026-06-11 — Shah Sujal (Insider)
2026-06-11 — HALL WALLACE L JR (Insider)
2026-06-11 — WYZGA MICHAEL S (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in TVRD insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

TVRD Insider Trading — FAQ

What is the latest insider trade for TVRD?: Tvardi Therapeutics, Inc. (TVRD) had 5 insider filings in the last 90 days, with the most recent on 2026-06-11. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying TVRD stock?: 0 insider purchases of TVRD were filed in the last 90 days.
How many insiders are selling TVRD stock?: 0 insider sales of TVRD were filed in the last 90 days.
Where can I see TVRD SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every TVRD SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live TVRD dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.